Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels - Erem,C.; Nuhoglu,I.; Yilmaz,M. (J Endocrinol Invest, 2009)